<DOC>
	<DOCNO>NCT01938508</DOCNO>
	<brief_summary>This study compare bioavailability two formulation 100 mg ( one capsule respectively ) one product , Minocycline , fast condition , healthy Mexican volunteer sex . The single dose study fasting ( 10 hour prior study ) condition , cross , two treatment , two period , two sequence ( 2x2 ) randomize sequence , balance , washout period least 7 day dose , 24 healthy volunteer .</brief_summary>
	<brief_title>Minocycline Bioequivalence Study</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Subjects age 18 55 year , gender . Subjects good health , base result complete medical history , valid 6 month prior baseline . Subjects laboratory study , liver transaminase , hepatitis B test C , HIV Venereal Disease Research Laboratory ( VDRL ) . These laboratory study issue within 6 month prior start study . Subjects 12lead ECG six month prior baseline normal normal physiologic variant . Subjects normal chest radiograph physiologically normal anatomic variant . Subjects negative result urine drug test . Subjects negative test alcoholometry . Female subject urine pregnancy test negative . Subjects Body Mass Index ( BMI ) range 19 26.5 kg/m2 . Subjects laboratory result within reference value +/ 10 % . And isolated abnormality 10 % consider low clinical relevance criterion Principal Investigator indicate relevance otherwise voluntary participation , long ensure safety volunteer . Subjects vital sign diastolic pressure 50 89 mmHg 90 139 mmHg systolic , pulse rate 55 100 beat per minute , respiratory rate 1224 breath per minute temperature 35.0 37.5 Â° C. Nonsmokers smoker smoke least 10 hour start study . Without alcohol intake 48 hour prior study drug administration . Subjects sign informed consent , inform potential risk benefit participation , willingness availability participate full study , may leave study time choose . Female participant must pregnant breastfeeding , plus sexually active method birth control prevent pregnancy investigation consider following secure method ( Male condom combine vaginal spermicide ( Foam , gel , film , cream , suppository , combine male condom female diaphragm , either without vaginal spermicide , intrauterine device also provide list contraceptive method order become pregnant investigation ) . Prior join first period sign commitment letter pregnancy . Subjects history hypersensitivity study drug drug belong group study drug . Subjects history cardiovascular disease , renal , hepatic , metabolic , gastrointestinal , neurological , endocrine , hematopoietic , psychiatric organic abnormality . Subjects require medication interfere quantification / kinetic study drug . Subjects expose agent know inducer inhibitor hepatic enzyme system . Subjects take potentially toxic drug within 30 day start study . Subjects take drug within 14 day 7 halflives start study . Subjects hospitalize reason seriously ill within 60 day study . Subjects receive investigational drug within 60 day start study . Subjects donate lose 450 mL blood within 45 day prior baseline . Subjects recent history drug abuse , include alcohol . Female subject positive pregnancy test urine . Subjects consume food beverage interact pharmacologically study drug ( particularly know source xanthine : caffeine , cola drink , theobromine , theophylline 10 hour test . Subjects grapefruit juice consumption 10 hour test . Subjects inability understand unwilling sign consent form . Subjects discharge database COFEPRIS participate another study bioequivalence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>dermatitis</keyword>
	<keyword>Minocycline</keyword>
	<keyword>bioavailability</keyword>
</DOC>